Manjit S. Bains
#150,339
Most Influential Person Now
Manjit S. Bains's AcademicInfluence.com Rankings
Manjit S. Bainsmedical Degrees
Medical
#2892
World Rank
#3336
Historical Rank
Surgery
#241
World Rank
#295
Historical Rank
Manjit S. Bainsphilosophy Degrees
Philosophy
#8283
World Rank
#11631
Historical Rank
Logic
#5320
World Rank
#6711
Historical Rank
Download Badge
Medical Philosophy
Manjit S. Bains's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Manjit S. Bains Influential?
(Suggest an Edit or Addition)Manjit S. Bains's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Incidence of local recurrence and second primary tumors in resected stage I lung cancer. (1995) (972)
- Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. (2008) (548)
- Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma (2004) (542)
- A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. (2001) (476)
- Thymoma: a multivariate analysis of factors predicting survival. (1995) (379)
- Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. (2009) (379)
- The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. (2004) (372)
- Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. (1993) (366)
- Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. (2004) (362)
- Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. (2003) (340)
- Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. (2001) (297)
- Lung resection for colorectal metastases. 10-year results. (1992) (275)
- Results of chest wall resection and reconstruction with and without rigid prosthesis. (2006) (273)
- Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. (1996) (251)
- Treatment of neoplastic epidural cord compression by vertebral body resection and stabilization. (1985) (250)
- Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications. (2008) (246)
- Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. (2005) (241)
- Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. (2000) (224)
- Adenocarcinoma of the Gastroesophageal Junction: Influence of Esophageal Resection Margin and Operative Approach on Outcome (2007) (220)
- Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer. (2018) (214)
- Proposed revision of the staging classification for esophageal cancer. (1998) (213)
- The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. (2006) (211)
- Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy (2017) (211)
- Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center (2007) (200)
- Malignant esophagorespiratory fistula: management options and survival. (1991) (191)
- New trends in skeletal reconstruction after resection of chest wall tumors. (1981) (185)
- TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. (2010) (184)
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. (1986) (183)
- Indications for pleurectomy in malignant effusion (1975) (182)
- Survival after resection of stage II non-small cell lung cancer. (1992) (178)
- Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. (2009) (178)
- Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients. (2000) (178)
- An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. (2002) (176)
- American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. (2007) (176)
- Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. (1994) (176)
- Incidence and risk factors for lung injury after lung cancer resection. (2007) (175)
- Bronchial carcinoids. Review of 124 cases (1985) (173)
- Superior sulcus tumors: CT and MR imaging. (1989) (171)
- The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0). (1988) (164)
- Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. (2002) (155)
- Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications. (1985) (154)
- Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. (2002) (152)
- Thymic carcinoma: current staging does not predict prognosis. (1998) (151)
- Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis. (2017) (151)
- The clamshell incision: an improved approach to bilateral pulmonary and mediastinal tumor. (1994) (149)
- Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. (2000) (146)
- Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. (2005) (146)
- Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. (1990) (141)
- Primary sarcomas of the mediastinum: results of therapy. (1998) (140)
- Extent of chest wall invasion and survival in patients with lung cancer. (1999) (140)
- Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. (2000) (139)
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors. (2016) (129)
- Esophageal Cancer Recurrence Patterns and Implications for Surveillance (2013) (127)
- Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. (1985) (125)
- Lobectomy improves ventilatory function in selected patients with severe COPD. (1998) (124)
- Pulmonary Metastasectomy for Head and Neck Cancers (1999) (123)
- Video-assisted thoracoscopic surgery (VATS) lobectomy: catastrophic intraoperative complications. (2011) (121)
- Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. (2006) (117)
- Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. (2006) (117)
- Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. (1983) (116)
- Comparison of patterns of relapse in thymic carcinoma and thymoma. (2008) (115)
- Predictors of survival in malignant tumors of the sternum. (1996) (115)
- Predictors of Outcomes after Surgical Treatment of Synchronous Primary Lung Cancers (2007) (114)
- Accuracy of lung imaging in metastases with implications for the role of thoracoscopy. (1993) (114)
- Effects of diltiazem versus digoxin on dysrhythmias and cardiac function after pneumonectomy. (1997) (111)
- Primary bony and cartilaginous sarcomas of chest wall: results of therapy. (1992) (110)
- Treatment and prognosis in bronchial carcinoids involving regional lymph nodes. (1994) (107)
- Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy (1985) (106)
- Soft tissue sarcomas of the chest wall. Results of surgical resection. (1991) (105)
- Results of surgical treatment of stage III lung cancer invading the mediastinum. (1987) (105)
- Combined chemotherapy and surgery in treatment of advanced germ‐cell tumors (1981) (104)
- Bronchial carcinoids. Review of 124 cases. (1985) (101)
- Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. (2003) (100)
- A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. (2002) (100)
- Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. (2008) (99)
- Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum. (2001) (98)
- Adenocarcinoma in Barrett's esophagus. (1983) (97)
- Unusual malignant neoplasms of the esophagus. Oat cell carcinoma, melanoma, and sarcoma. (1991) (92)
- Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer. (2006) (91)
- Post-treatment Endoscopic Biopsy Is a Poor-Predictor of Pathologic Response in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer (2009) (91)
- A prospective trial comparing pain and quality of life measures after anatomic lung resection using thoracoscopy or thoracotomy. (2014) (91)
- Management of non-small cell lung cancer with direct mediastinal involvement. (1994) (90)
- Vertebral body resection in the treatment of cancer involving the spine (1984) (89)
- Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers (2013) (88)
- Pulmonary metastasectomy with therapeutic intent for soft‐tissue sarcoma (2017) (87)
- Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. (1999) (86)
- Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. (1998) (85)
- Gastric transposition for head and neck cancer: a critical update. (1991) (84)
- Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging. (1994) (84)
- Predictive Value of Initial PET-SUVmax in Patients with Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma (2009) (84)
- Combined thoracoscopic and laparoscopic robotic-assisted minimally invasive esophagectomy using a four-arm platform: experience, technique and cautions during early procedure development. (2013) (82)
- Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: a randomized clinical trial. (1996) (78)
- Feasibility of multimodality therapy including extended resections in stage IVA thymoma. (2007) (78)
- Pulmonary resection in metastatic carcinoma. (1978) (77)
- Symptomatic tachydysrhythmias after esophagectomy: incidence and outcome measures. (1996) (76)
- A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. (2002) (74)
- Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors. (2018) (72)
- Lymphadenectomy for Adenocarcinoma of the Gastroesophageal Junction (GEJ): Impact of Adequate Staging on Outcome (2007) (72)
- Chest wall resection for locally recurrent breast cancer: is it worthwhile? (2000) (71)
- Adenocarcinoma in situ of Barrett's esophagus diagnosed by endoscopic cytology. (1974) (71)
- Combined modality chemoradiation in elderly oesophageal cancer patients (2007) (71)
- Medical tumors of the chest wall. Solitary plasmacytoma and Ewing's sarcoma. (1993) (71)
- Surgical treatment of superior sulcus tumors with spinal and brachial plexus involvement. (2002) (68)
- Surgical management of thoracic malignancies invading the heart or great vessels. (2004) (67)
- Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer (2012) (67)
- Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy. (2004) (65)
- Barium sulfate: a new (old) contrast agent for diagnosis of postoperative esophageal leaks. (1997) (65)
- Management of major hemorrhage during mediastinoscopy. (2003) (64)
- Carcinomatous involvement of the hilum and mediastinum: computed tomographic and magnetic resonance evaluation. (1985) (63)
- FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography. (1999) (62)
- The treatment of extragonadal seminoma. (1984) (62)
- Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. (2012) (61)
- Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. (2007) (61)
- DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors. (2008) (60)
- Cisplatin and bleomycin in the treatment of esophageal carcinoma: A final report (1984) (60)
- Neuroendocrine Differentiation in the Glandular Peripheral Nerve Sheath Tumor: Pathologic Distinction from the Biphasic Synovial Sarcoma with Glands (1988) (60)
- Attaining Proficiency in Robotic-Assisted Minimally Invasive Esophagectomy While Maximizing Safety during Procedure Development (2016) (60)
- Radical nephrectomy with vena caval thrombectomy: a contemporary experience (2011) (59)
- Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer. (2011) (58)
- Gastric transposition in head and neck surgery. Indications, complications, and expectations. (1983) (57)
- Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensitizing Mutations in the Tyrosine Binding Domain of the EGFR Gene (2011) (56)
- Intraoperative Near-Infrared Fluorescence Imaging as an Adjunct to Robotic-Assisted Minimally Invasive Esophagectomy (2014) (53)
- Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. (2008) (53)
- Combined modality therapy of esophageal carcinoma (1981) (52)
- Surgical treatment of lung cancer. (1991) (52)
- Renal cell carcinoma extending into inferior vena cava. (1983) (51)
- Vocal cord medialization for unilateral paralysis associated with intrathoracic malignancies. (1996) (51)
- Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy. (2019) (50)
- Contemporary Results of Surgical Resection of Non-small Cell Lung Cancer After Induction Therapy: A Review of 549 Consecutive Cases (2011) (49)
- Pediatric chest wall Ewing's sarcoma. (2000) (49)
- A comparison of pulmonary function tests for postthoracotomy pain using cryoanalgesia and transcutaneous nerve stimulation. (1986) (48)
- Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases (2018) (48)
- Combined-modality therapy of esophageal cancer. (1984) (47)
- Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin (1982) (47)
- Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non‐small cell lung cancer (1994) (46)
- The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours (2003) (45)
- Vindesine in the treatment of esophageal carcinoma: a phase II study. (1979) (43)
- Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center (2011) (42)
- Management and outcomes of relapse after treatment for thymoma and thymic carcinoma. (2011) (41)
- Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma. (1983) (40)
- VATS Port Site Recurrence: A Technique Dependent Problem (2001) (38)
- Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer. (1986) (38)
- Surgical treatment of metastatic sarcoma to the lung. (1974) (38)
- Treatment of esophageal carcinoma combined preoperative chemotherapy. (1982) (38)
- Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery (2019) (37)
- Giant benign esophageal schwannoma requiring esophagectomy. (2006) (36)
- Resection of lung cancer invading the diaphragm. (1997) (35)
- Type I Thyroplasty for Acute Unilateral Vocal Fold Paralysis following Intrathoracic Surgery (2002) (34)
- Endoscopic placement of direct percutaneous jejunostomy tubes in patients with complications after esophagectomy. (2003) (34)
- Methods of skeletal reconstruction following resection of lung carcinoma invading the chest wall. (1987) (34)
- Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors. (2016) (33)
- Endoscopic retrograde dilation of completely occlusive esophageal strictures. (2006) (33)
- Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. (1995) (33)
- Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma (2018) (33)
- Endoscopic Management of Esophageal Anastomotic Leaks After Surgery for Malignant Disease. (2016) (32)
- Surgery for solitary and multiple pulmonary metastases. (1978) (32)
- Prognostic Factors After Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus (2007) (31)
- Pharyngolaryngectomy, total extrathoracic esophagectomy and gastric transposition. (1979) (31)
- Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy. (2014) (30)
- Results of combined chemo‐surgical therapy for pulmonary metastases from testicular carcinoma (1978) (29)
- Esophagobronchial fistula closure using a novel endoscopic over-the-scope-clip. (2012) (28)
- Abnormal gallium scintigraphy in Pneumocystis carinii pneumonia with a normal chest radiograph. (1978) (28)
- Pretreatment Dysphagia in Esophageal Cancer Patients May Eliminate the Need for Staging by Endoscopic Ultrasonography. (2016) (27)
- Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma (2016) (27)
- Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors. (2014) (27)
- Phrenic nerve injury resulting from percutaneous ablation of lung malignancy. (2008) (26)
- Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. (2019) (25)
- Local recurrent mammary carcinoma failing multimodality therapy. A solution. (1989) (25)
- Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma. (1981) (25)
- Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer. (2018) (25)
- Patterns of symptoms following surgery for esophageal cancer. (2013) (24)
- Surgical Treatment of Spinal Cord Compression in Patients with Lung Cancer (1985) (24)
- Comprehensive long-term care of patients with lung cancer: development of a novel thoracic survivorship program. (2014) (23)
- Esophageal involvement in Wegener's granulomatosis. (1994) (23)
- Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma (2017) (22)
- Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma? (2017) (22)
- Indications for surgery for intrathoracic metastases in testicular carcinoma. (1979) (21)
- Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer. (2016) (21)
- Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy. (2016) (20)
- Paraspinal tumors: techniques and results of brachytherapy. (1991) (20)
- A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report. (1997) (20)
- Phase II study of etoposide in the treatment of esophageal carcinoma. (1983) (20)
- cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomas. (1978) (19)
- Esophageal intramural hematoma: a painful condition that may mimic an esophageal mass. (2002) (19)
- Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients. (2013) (19)
- Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain. (2020) (18)
- Two-Year Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy. (2019) (18)
- Role of chemotherapy and surgery in the treatment of thoracic metastases from nonseminomatous germ cell testis tumor (1982) (18)
- A novel method of one-lung isolation using a double endobronchial blocker technique. (2001) (17)
- Early operative outcomes and learning curve of robotic assisted giant paraesophageal hernia repair (2017) (17)
- Does pyloric drainage have a role in the era of minimally invasive esophagectomy? (2018) (17)
- Combined modality therapy in esophageal cancer: the Memorial experience. (2003) (17)
- Complications of abdominal right-thoracic (Ivor Lewis) esophagectomy. (1997) (17)
- The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma. (2016) (17)
- Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis. (2009) (16)
- High-frequency jet ventilation during thoracic surgical procedures. (1987) (16)
- Solitary plasmacytoma and Ewing's sarcoma (1993) (16)
- Computed Tomography-Guided Access to the Cisterna Chyli: Introduction of a Technique for Direct Lymphangiography to Evaluate and Treat Chylothorax (2011) (15)
- How Many Nodes Need to be Removed to Make Esophagectomy an Adequate Cancer Operation, and Does the Number Change When a Patient has Chemoradiotherapy Before Surgery? (2019) (15)
- Contribution of videothoracoscopy to the management of the cancer patient (1994) (15)
- Chylothorax and Recurrent Laryngeal Nerve Injury Associated with Robotic Video-Assisted Mediastinal Lymph Node Dissection (2015) (15)
- High dose-rate intraluminal brachytherapy for carcinoma of the esophagus (1996) (15)
- Echoplanar MR imaging for characterization of adrenal masses in patients with malignant neoplasms: preliminary evaluation of calculated T2 relaxation values. (1995) (15)
- Herniation of the transverse colon after esophagectomy: is retrocardiac air a normal postoperative finding? (1997) (14)
- Surgical Treatment in Non-Small Cell Carcinoma of the Lung: The Memorial Sloan-Kettering Experience (1988) (13)
- Resection of Primary and Secondary Tumors of the Sternum: An Analysis of Prognostic Variables. (2015) (13)
- Magnetic Resonance Imaging of the Postpneumonectomy Chest: Normal and Abnormal Findings (1997) (12)
- Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience. (2016) (12)
- Human pulmonary dirofilariasis mimicking metastatic disease. (1981) (12)
- Prevalence of occult peribronchial N1 nodal metastasis in peripheral clinical N0 <2 cm NSCLC. (2020) (12)
- Ivor Lewis esophagectomy. (1995) (12)
- Chest Wall Reconstruction Using a Methyl Methacrylate Neo-Rib and Mesh. (2015) (12)
- Phase II study of methyl-GAG in the treatment of esophageal carcinoma. (1982) (11)
- Positron‐Emission Tomography Scan–Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron‐Emission Tomography Nonresponders (2019) (11)
- Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab (2013) (11)
- Time-varying analysis of readmission and mortality during the first year after pneumonectomy. (2020) (11)
- Unique Considerations for Females Undergoing Esophagectomy. (2020) (11)
- Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT). (2013) (10)
- Association of genomic alterations with cisplatin resistance (cisR) in advanced germ cell tumors (aGCT) (2015) (10)
- Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma. (2018) (10)
- Multipurpose central venous access using the cordis sheath introducer system. (1979) (10)
- Phase II trial of preoperative combined modality therapy for esophageal carcinoma: Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy (2005) (10)
- Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall. (2020) (10)
- New intraoperative brachytherapy techniques for positive or close surgical margins (1989) (10)
- Primary melanocarcinoma of the esophagus. (1979) (9)
- Open Surgical Approaches for Pulmonary Metastasectomy. (2016) (9)
- Radiographic and endoscopic features of a congenital duodenal diaphragm in an adult. A case report and review of the literature. (1980) (9)
- Final report of the 70.2 GY and 75.6 GY dose levels of a phase I dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer (1998) (9)
- Bronchogenic carcinoma with invasion of the spine. Treatment with combined surgery and perioperative brachytherapy. (1982) (9)
- Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer (2021) (9)
- Innominate Artery Fistula Caused by Laryngectomy Tube (1983) (9)
- Massive leiomyosarcoma of the chest wall in a young child. (1980) (9)
- Long-term, disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis. (2020) (9)
- A More Extensive Lymphadenectomy Enhances Survival After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Adenocarcinoma (2020) (9)
- Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma. (2012) (9)
- Neoadjuvant chemotherapy and surgery of cancer of the esophagus. (1990) (8)
- Adjuvant brachytherapy for treatment of chest wall sarcomas. (1991) (8)
- Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma. (2016) (8)
- Induction chemotherapy employing dose‐intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma (1999) (8)
- Management dilemmas due to a paratracheal follicular dendritic cell tumor. (2006) (8)
- Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors (2020) (8)
- Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. (2014) (7)
- Surgical treatment of spinal cord compression in patients with lung cancer. (1985) (7)
- Ongoing Challenges in Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma. (2018) (7)
- Phase II trial of preoperative cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy: PET scan after induction therapy may identify early treatment failure. (2006) (7)
- The AJCC staging system does not predict survival in patients receiving multimodality therapy for esophageal cancer (2005) (7)
- Palliative prosthetic intubation in gastric cancer (1980) (6)
- Impact on Pulmonary Complications After Thoracotomy (2005) (6)
- Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin. (2009) (6)
- Medical imaging in lung cancer. (1987) (6)
- Performance Comparison between SURPAS and ACS NSQIP Surgical Risk Calculator in Pulmonary Resection. (2020) (5)
- Radiographic appearances of esophageal stents. (1997) (5)
- Bypass graft for femoral artery involvement by metastatic carcinoma of the penis. (1982) (5)
- Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts) (2005) (5)
- Prospective comparison of postoperative quality of life (QOL) in patients undergoing lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for non-small cell lung cancer (NSCLC) (2008) (5)
- How Effective Is Neoadjuvant Therapy Followed by Surgery for Pathologic Single-Station N2 Non-Small Cell Lung Cancer? (2020) (5)
- A new endobronchial implanter. (1979) (5)
- Recurrence of resected esophagogastric adenocarcinoma: Results of re‐resection (1990) (4)
- High- and low-dose-rate intraoperative radiotherapy for thoracic malignancies resected with close or positive margins. (2016) (4)
- Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancer (2021) (4)
- Morbidity and mortality for pulmonary resections in lung cancer after induction treatment (2000) (4)
- Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors. (2015) (4)
- Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience (2018) (4)
- Oligometastases After Curative Esophagectomy Are Not One-Size-Fits-All. (2021) (4)
- Intra-thoracic cytoreduction of stage IV peritoneal malignancy: a case series. (2008) (3)
- Use of vasopressors during esophagectomy is not associated with increased risk of anastomotic leak. (2020) (3)
- Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts. (2009) (3)
- Clinical microbiological case: refractory chest wall infection following reconstructive surgery in a patient with relapsed lung cancer. (2001) (3)
- Treatment of anastomotic recurrence after esophagectomy. (2021) (3)
- Randomized clinical trials in esophageal cancer. (2002) (3)
- Propensity-matched Analysis Demonstrates Long-term Risk of Respiratory and Cardiac Mortality After Pneumonectomy Compared With Lobectomy for Lung Cancer (2020) (3)
- Defining low-risk lesions in early-stage esophageal adenocarcinoma. (2020) (3)
- Treatment of primary malignant "coin lesions" of the lung. (1974) (2)
- Complex chest wall surgery to prevent vascular complications after immunotherapy and radiation treatment (2020) (2)
- Quality of Endoscopy Reports for Esophageal Cancer Patients: Where Do We Stand? (2018) (2)
- Drs Gollub and Bains respond (1997) (2)
- Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT). (2013) (2)
- Assessing the clinical feasibility of implementing a novel assessment of frailty: The electronic Rapid Fitness Assessment in diverse thoracic surgery clinics. (2017) (2)
- O-075 Malignant pleural mesothelioma (MPM): New predictors ofsurvival and an analysis of the impact of current treatment (2005) (2)
- Anesthesia for the application of endotracheal and endobronchial radiation therapy. (1984) (2)
- Causes of obstruction of prosthetic esophageal tubes and their prevention: a case report and review of the literature. (1979) (2)
- Survival Following Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter? (2020) (2)
- THE ROLE OF THORACOTOMY IN THE MANAGEMENT OF POSTCHEMOTHERAPY RESIDUAL THORACIC MASSES (1999) (2)
- Thoracic Metastasectomy in Germ Cell Tumor Patients Treated with First-Line Versus Salvage. (2020) (2)
- DNA Damage and Repair Capacity in Lung Cancer Patients: Prediction of Multiple Primary Tumors (2015) (2)
- Early implementation of a perioperative nutrition support pathway for patients undergoing esophagectomy for esophageal cancer (2021) (2)
- Recent Clinical Experience with Multimodality Therapy in Thymic Carcinoma: P1-128 (2007) (2)
- Type A thymoma presenting with bone metastasis (2018) (2)
- A prospective trial of intraoperative tissue oxygenation measurement and its association with anastomotic leak rate after Ivor Lewis esophagectomy (2020) (2)
- Management of the Apical Tumor: May 4, 2013, Minneapolis, MN. (2013) (2)
- Role of PET scan in predicting response to neoadjuvant chemotherapy and long-term outcomes for stage II lung cancer. (2014) (2)
- Real-time intraoperative tissue oxygenation monitoring by wireless pulse oximetry (WiPOX) to assess gastric conduit oxygenation during esophagogastrectomy: A prospective feasibility study (2011) (2)
- Recent clinical experience with multimodality therapy in thymic carcinoma (2007) (2)
- Can induction chemotherapy improve dysphagia in locally advanced esophageal/GEJ cancer? (2014) (2)
- Assessing Pulmonary Variables In Predicting Post-Thoracotomy Complications (2004) (1)
- Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinoma. (2022) (1)
- PET scan-directed chemoradiation (CRT) for esophageal squamous cell carcinoma (ESCC): No benefit for salvage chemo in PET non-responders (PETnr). (2018) (1)
- Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma. (2021) (1)
- Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma (2021) (1)
- Follicular Dendritic Cell Sarcoma of the Chest. (2021) (1)
- 2152 Phase II trial of combined surgical resection, high dose rate intraoperative radiation therapy, and external beam radiotherapy for malignant pleural mesothelioma (1997) (1)
- Cisplatin, vindesine, and bleomycin combination chemotherapy of esophageal cancer (1981) (1)
- Use of SUVmax to predict response to neoadjuvant chemoradiotherapy in patients with adenocarcinoma of the distal esophagus and GE Junction (2008) (1)
- Factors influencing outcome after pulmonary resection for colorectal cancer (CRC) metastases in the current era (2008) (1)
- One-lung isolation using a double-balloon blocker technique. (2005) (1)
- Does endoscopy accurately predict response to chemoradiation in patients undergoing esophagectomy? (2006) (1)
- Phase I/II Study of Paclitaxel Plus Ifosfamide Followed By High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors (2014) (1)
- Resection of primary nonseminomatous germ cell tumors of the anterior mediastinum: A 28-year experience at Memorial Sloan-Kettering Cancer Center (2009) (0)
- The Role of Surgical Resection Following Primary Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma: A Decision Analysis (2011) (0)
- Changing chemotherapy (C) with concurrent radiation (RT) followed by surgery after sub-optimal FDG-PET response to induction chemotherapy improves outcomes in locally advanced (LA) esophageal adenocarcinoma (EA). (2015) (0)
- Female gender is an independent predictor of superior perioperative survival following non-small cell lung cancer (NSCLC) resection. (2006) (0)
- Preoperative endoscopic ultrasound predicts the risk of recurrence and mortality after surgery for esophageal carcinoma (1996) (0)
- Tu1036 Ensuring Quality of Information in an Era of Multidisciplinary Care: Compliance With Established Quality Indicators for the Initial Endoscopic Assessment of Esophageal Cancer Patients (2017) (0)
- Whole B ody 18 FDG-PET a nd t he R esponse o f E sophageal Cancer t o I nduction T herapy: R esults o f a P rospective T rial (2003) (0)
- Prolonged venoarterial bypass with membrane pump oxygenator. (1972) (0)
- FDG-PET scan after induction chemotherapy for esophageal squamous cell cancer (ESCC) to predict for outcomes after chemoradiation (chemoRT) and to guide salvage chemotherapy during RT. (2014) (0)
- Treatment Variability for Locally Advanced Esophageal Cancer in the United States and its Effect on Long-Term Outcomes (2017) (0)
- Neoadjuvant therapy of esophageal cancer. (1997) (0)
- 856 NODAL METASTASES AFTER NEOADJUVANT CHEMORADIATION AND R0 RESECTION IN ESOPHAGEAL ADENOCARCINOMA: PATTERNS AND PROGNOSIS (2021) (0)
- Pulmonary resection in metastatic carcinoma. 1978. (2009) (0)
- PD-124 Survival after mechanical ventilation for complications after pneumonectomy (2005) (0)
- Esophageal Gastrointestinal Stromal Tumors: A Single-Institution Experience (2017) (0)
- Tu1591 Learning Curve for Combined Thoracoscopic and Laparoscopic Robotic-Assisted Minimally Invasive Esophagectomy Using a Four-Arm Platform (2014) (0)
- Genetic Determinants of Chemoradiation Response and Survival in Locally Advanced Esophageal Carcinoma Treated with Trimodality Therapy (2019) (0)
- Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer. (2022) (0)
- Small cell carcinoma of the esophagus: Review of the Memorial Sloan-Kettering Cancer Center (MSKCC) experience (2007) (0)
- O-105 Simultaneous bilateral thoracotomy for resection of bilateral pulmonary metastases: A safe and effective approach (2003) (0)
- RESPIRATORY COMPLICATIONS AFTER ESOPHAGOGASTRECTOMY (1981) (0)
- Waiting to Operate (2023) (0)
- Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT). (2019) (0)
- Let the BBC know if you see a nursing error in casualty (2013) (0)
- Comparison of Trimodality Therapy to Chemoradiation Alone in a Large Cohort of Patients With Adenocarcinoma of the Esophagus (2015) (0)
- PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA). (2020) (0)
- 161 Phase II trial of combined surgical resection, intraoperative high dose rate brachytherapy (IORT), and external beam radiation therapy (ESRT) for malignant pleural mesothelioma (MPM) (1996) (0)
- Impact of pre-operative chemoradiotherapy on post-esophagectomy morbidity and mortality. (2006) (0)
- Translating Telemedicine to Thoracic Surgical Oncological Care: Performance Analysis and Patient Perceptions During the COVID-19 Pandemic. (2022) (0)
- Synchronous Esophageal and Lung Cancers - Is Combined Anatomic Resection Appropriate? (2021) (0)
- RETROSPECTIVE REVIEW OF THE MSKCC EXPERIENCE WITH RESECTION OF RENAL MASSES AND ASSOCIATED VENA CAVAL THROMBI (2009) (0)
- Thoracic Track Abstracts (2011) (0)
- POSTER PRESENTATIONS: Multi-purpose central venous access using the Cordis catheter sheath system (1978) (0)
- O-31 18FDG-PET SUV: Prognostic value for surgically treated lung cancer (2003) (0)
- A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients with Esophageal Adenocarcinoma (2023) (0)
- Canyons and Volcanoes: The Effects of Radiation on the Chest Wall. (2021) (0)
- The association of PET response with complete pathological response (CPR) and residual nodal disease (RND) after induction chemoradiotherapy (CRT) and resection of esophageal cancer: A review of 493 cases. (2009) (0)
- Biosandwich technique for extensive chest wall reconstruction in patients with complex defects. (2023) (0)
- Su1503 Dysphagia Relief and Adverse Events Associated With Fully Covered Evolution® Esophageal Stents in Malignant Esophageal Strictures: Does Size Matter? (2013) (0)
- Reply to L.H. Einhorn et al (2010) (0)
- P-933 Selective use of a rigid prosthesis for chest wall reconstructionafter chest wall resection reduces respiratory complication rates (2005) (0)
- Long-Term Resul ts of Combined-Modal i ty Therapy in Resectable Non – Smal l-Cel l Lung Cancer (2002) (0)
- Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes (2022) (0)
- 943 - Outcomes of Radiation Induced Squamous Cell Carcinoma are Suggestive of a Very Aggressive Disease (2018) (0)
- Distinct Differences in Gastroesophageal Junction and Gastric Adenocarcinoma in 2194 Patients (2021) (0)
- Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy (2022) (0)
- Is routine chest radiography necessary after endobronchial ultrasound-guided fine needle aspiration? (2020) (0)
- Postoperative Pulmonary Complications after Neoadjuvant Chemoradiotherapy with IMRT for Esophageal Cancer (2010) (0)
- Operative Time Is Associated with Postoperative Complications After Pulmonary Lobectomy. (2022) (0)
- PO-391 INTRAOPERATIVE BRACHYTHERAPY FOR THORACIC MALIGNANCIES RESECTED WITH CLOSE OR POSITIVE MARGINS (2012) (0)
- Spray Cryotherapy for Malignant Airway Obstruction: A Single Institutional Experience (2011) (0)
- F-123QUALITY OF LIFE AND PAIN OUTCOMES AFTER ROBOTIC-ASSISTED MINIMALLY INVASIVE OESOPHAGECTOMY AND OPEN OESOPHAGECTOMY: SHORT-TERM RESULTS OF A PROSPECTIVE TRIAL (2015) (0)
- Paclitaxel, I fosfamide, a nd C isplatin S econd-Line T herapy for P atients W ith R elapsed T esticular G erm C ell C ancer (2000) (0)
- OA01.03 Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Stage I NSCLC Patients: A Competing Risk Analysis (2017) (0)
- Minimal residual local disease predicts improved survival after chemoradiotherapy in patients with squamous cell carcinoma of the esophagus (2007) (0)
- Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort. (2021) (0)
- O-025KRAS MUTATION PREDICTS WORSE OVERALL SURVIVAL IN CLINICAL STAGE IIIA LUNG ADENOCARCINOMA PATIENTS TREATED WITH INDUCTION CHEMOTHERAPY FOLLOWED BY SURGERY (2015) (0)
- Patient-reported symptom frequency and distress after open and minimally invasive esophagectomy. (2015) (0)
- for bronchioloalveolar carcinoma Clinical pattern and pathologic stage but not histologic features predict outcome (2013) (0)
- Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma (2020) (0)
- Silicone-Covered Self-Expanding Polyester Stents for the Closure of Thoracic Anastomotic Leaks After Esophagectomy (2008) (0)
- Nael Martini: a leader in thoracic surgical oncology. (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Manjit S. Bains?
Manjit S. Bains is affiliated with the following schools:
